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ABSTRACT
Here we report investigations, based on circu-
lar dichroism, nuclear magnetic resonance spec-
troscopy, molecular modelling, differential scanning
calorimetry and prothrombin time assay, on ana-
logues of the thrombin binding aptamer (TBA) in
which individual thymidines were replaced by 5-
fluoro-2′-deoxyuridine residues. The whole of the
data clearly indicate that all derivatives are able to
fold in a G-quadruplex structure very similar to the
‘chair-like’ conformation typical of the TBA. However,
only ODNs TBA-F4 and TBA-F13 have shown a re-
markable improvement both in the melting temper-
ature (Tm ≈ +10) and in the anticoagulant activity
in comparison with the original TBA. These findings
are unusual, particularly considering previously re-
ported studies in which modifications of T4 and T13
residues in TBA sequence have clearly proven to be
always detrimental for the structural stability and bi-
ological activity of the aptamer. Our results strongly
suggest the possibility to enhance TBA properties
through tiny straightforward modifications.
INTRODUCTION
DNA and RNA aptamers are nucleic acid ligands charac-
terized by an outstanding ability to bind with high affin-
ity and specificity to various molecular targets such as
small molecules, proteins, nucleic acids, and even cells,
tissues and organisms. Aptamers can be discovered and
engineered through repeated rounds of an in vitro se-
lection strategy called SELEX (Systematic Evolution of
Ligands by Exponential enrichment) (1,2). Among the
DNA aptamers the thrombin binding aptamer (TBA, 5′-
GGTTGGTGTGGTTGG-3′) has been one of the first to
be discovered (3,4). However, despite this fact, TBA is still
the subject of several researches, both in therapeutics, be-
ing endowed with anticoagulant properties, and in analyt-
ics, thank to its ability of binding potassium ions and, more
importantly, also heavy metal ions of toxicological interest.
According to nuclear magnetic resonance (NMR) andX-
ray structural investigations TBA adopts a monomolecular,
antiparallel G-quadruplex structure with a ‘chair-like’ con-
formation (5,6). The central part of the G-quadruplex con-
sists of two syn-anti-syn-anti stacked G-quartets, which are
connected to each other by three edge-wise loops: a cen-
tral TGT loop and two lateral TT loops (Figure 1). Quite
soon after its discovery, TBA has been subjected to several
chemical modifications, most of which with the targets to:
(i) improve its thermal stability in physiological conditions,
which is connected to the anticoagulant activity; (ii) render
it resistant to the exonucleases, ubiquitous in biological en-
vironments and (iii) enhance its affinity to thrombin.
As far as the TBA/thrombin interaction is concerned, a
compelling number of investigations have highlighted that
the loops are the parts of the aptamer mostly involved in
the interaction with the protein (6–8). In particular, these
studies indicated that the minor loops TT interact with the
thrombin anion exosite I, while the larger TGT loop is in
close proximity to the heparin binding site of a further
thrombin molecule. Therefore, TBA seems to interact with
two thrombin molecules, inactivating only one of them.
The availability of rather detailed information on which
residues were involved in the interaction of TBA with its
target allowed researchers to propose a number of interest-
ing site specific modifications aimed at obtaining data con-
cerning the quantitative structure-activity and/or structure-
stability relationship. In fact, by limiting our discussion to
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Figure 1. Schematic representation of the TBA G-quadruplex and chem-
ical structure of 5-fluoro-2′-deoxyuridine (F). Guanosines in syn and anti
glycosidic conformations are in dark and light grey, respectively.
single thymidine replacements, the physical-chemical and
biological properties of several properly synthesized TBA
analogues have been investigated. For example, concern-
ing the sugar-phosphate backbone, TBA derivatives have
been proposed in which thymidines have been substituted
with locked nucleic acid residues (LNA-T) (9), unlocked
nucleic acid residues (UNA-U) (10,11) and other types of
acyclic thymidines (12–14), and L-residues (15). Recently,
studies concerning TBA analogues containing D- and L-
isothymides have been also described (16). Furthermore, ex-
pressly synthesized TBA derivatives have been investigated
in which formacetal (17), thiophosphoryl (18) and triazole
(19) internucleotide linkages were present.
The general overview, which can be inferred by the lit-
erature data, is that enhancements of the thermal stabil-
ity or anticoagulant activity or, in some cases both, are
more likely if the modifications concern residues T3, T7 and
T12 (9-14). Conversely, residues T4, T13 and, in a less ex-
tent, T9 have resulted very critical both for thermal stabil-
ity and/or anticoagulant activity (10,12,16). As a matter
of fact, almost all replacements concerning these residues
have caused a drop for both the physical-chemical and bi-
ological properties of the resulting modified aptamers. Sur-
prisingly, only TBA derivatives containing a few types of
thymines analogues (13,14,20) or abasic sites (21,22) have
been studied, notwithstanding the not negligible availability
of modified thymidines phosphoramidites from commer-
cial sources. However, although only a few studies are avail-
able concerning the replacement of thymines with modified
(13,14,20) or other natural bases (23,24), the collected data
confirm the critical role of residues T4 and T13 already ob-
served for backbone modifications.
In this frame, we have undertaken a systematic in-
vestigation of new TBA derivatives containing modified
thymines in order to acquire further data concerning both
the structure-stability and the structure-activity relation-
ship in the aptamer/target interaction. Here we describe the
structural and biological properties of TBA analogues in
which single thymidines have been replaced with 5-fluoro-
2′-deoxyuridine residues (F) (Figure 1 and Table 1). For
the first time and in contrast to most of the results de-
scribed in literature up to date, the collected data from circu-
lar dichroism (CD) experiments, NMR techniques (1H and
19F), molecular modelling, differential scanning calorime-
try (DSC) and prothrombin time (PT) assay measurements
have clearly shown significant improvements for both the
physical-chemical and biological properties in TBA deriva-
tives, where residues T4 and T13 have been replaced with
F. These results are particularly noteworthy taking into ac-
count that they have been obtained with TBA analogues in
which a single fluorine atom replaces a methyl group in the
original structure.
MATERIALS AND METHODS
Oligonucleotides synthesis and purification
The oligonucleotides reported in Table 1 were synthesized
on a Millipore Cyclone Plus DNA synthesizer using
solid phase -cyanoethyl phosphoramidite chemistry
at 15 mol scale. The modified monomer was intro-
duced in the sequences using commercially available
5′-O-(4,4′-dimethoxytrityl)-5-fluoro-2′-deoxyuridine-3′-O-
(2-cyanoethyl-N,N-diisopropyl)phosphoramidite (Glen
Research). The oligomers were detached from the support
and deprotected by treatment with concentrated aqueous
ammonia at room temperature for 24 h.
The combined filtrates and washings were concentrated
under reduced pressure, redissolved in H2O, analysed and
purified by high-performance liquid chromatography on a
Nucleogel SAX column (Macherey-Nagel, 1000–8/46), us-
ing buffer A: 20 mM NaH2PO4/Na2HPO4 aqueous solu-
tion (pH 7.0) containing 20% (v/v) CH3CN and buffer B:
1 M NaCl, 20 mM NaH2PO4/Na2HPO4 aqueous solution
(pH 7.0) containing 20% (v/v) CH3CN; a linear gradient
from 0 to 100% B for 45 min and flow rate 1 ml/min were
used. The fractions of the oligomers were collected and suc-
cessively desalted by Sep-pak cartridges (C-18). The iso-
lated oligomers proved to be >98% pure by NMR.
CD and UV spectroscopy
CD samples of modified oligonucleotides and their natu-
ral counterpart were prepared at an oligodeoxynucleotide
(ODN) concentration of 100 M using a potassium phos-
phate buffer (10 mM KH2PO4/K2HPO4, 70 mM KCl, pH
7.0) and submitted to the annealing procedure (heating at
90◦C and slowly cooling at room temperature). CD spectra
of all quadruplexes and CD melting curves were registered
on a Jasco J-715 CD spectrophotometer. For the CD spec-
tra, thewavelengthwas varied from 220 to 320 nmat 100 nm
min−1 scan rate, and the spectra recorded with a response
of 16 s, at 2.0 nm bandwidth and normalized by subtraction
of the background scan with buffer. The temperature was
kept constant at 20◦C with a thermoelectrically-controlled
cell holder (Jasco PTC-348). CD melting curves were regis-
tered as a function of temperature from 20 to 80◦C for all
quadruplexes at their maximum Cotton effect wavelengths.
The CD data were recorded in a 0.1 cm pathlength cuvette
with a scan rate of 0.5◦C/min. The CDmelting curves were
modelled by a two-state transition according to the van’t
Hoff analysis (25). The melting temperature (Tm), the en-
thalpy change (Hv.H.) and the entropy change (Sv.H.) val-
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Table 1. TBA analogues investigated and their thermodynamic parameters, obtained from the analysis of the CD melting curves
Name Sequence (5′-3′) Tm (◦C) (± 1) Tm Hv.H. (kJ/mol)a Sv.H. (kJ/mol K)a
TBA GGTTGGTGTGGTTGG 50 154 0.48
TBA-F3 GGFTGGTGTGGTTGG 52 +2 178 0.55
TBA-F4 GGTFGGTGTGGTTGG 61 +11 196 0.59
TBA-F7 GGTTGGFGTGGTTGG 53 +3 163 0.50
TBA-F9 GGTTGGTGFGGTTGG 52 +2 201 0.62
TBA-F12 GGTTGGGTTGGFTGG 51 +1 178 0.55
TBA-F13 GGTTGGGTTGGTFGG 60 +10 204 0.61
aThe errors on Hv.H. and Sv.H. are within the 10%.
F = 5-fluoro-2′-deoxyuridine.
ues (Table 1) provide the best fit of the experimental melting
data.
The UV melting experiments were carried out with a
Cary 5000 UV-vis spectrophotometer equipped with a ther-
mostated cell compartment, using quartz cuvettes with 1
cm path lengths. UV samples were prepared at a concen-
tration of 4 M in the same buffer used for CD experi-
ments. The UV melting curves were obtained by following
the absorbance change at 295 nm in the 20–85◦C tempera-
ture range using a scan rate of 0.5◦C/min.
Differential scanning calorimetry
Differential scanning measurements were performed on a
last generation nano-DSC (TA Instruments). The excess
molar heat capacity function CP was obtained after a
baseline subtraction, assuming that the baseline is given by
the linear temperature dependence of the native-state heat
capacity (26). A buffer versus buffer scan was subtracted
from the sample scan. All systems were tested for reversibil-
ity by running the heating and cooling curves at the same
scan rate of 1◦C min−1. The process enthalpies, H◦, were
obtained by integrating the area under the heat capacity
versus the temperature curves. Tm is the temperature corre-
sponding to the maximum of each DSC peak. Entropy val-
ues were obtained by integrating the curveCp/T versus T
(whereCp is themolar heat capacity and T is the tempera-
ture in Kelvin). The thermodynamic parameters in Supple-
mentary Table S1 represent averages of heating curves from
three to five experiments. The reported errors for thermody-
namic parameters are the standard deviations of the mean
from the multiple determinations. The measurements were
performed with a DNA strand concentrations in the range
250–300 M.
Polyacrylamide gel electrophoresis
All oligonucleotides were analysed by non-denaturing poly-
acrylamide gel electrophoresis (PAGE). Samples in the
NMR buffer (10 mM KH2PO4, 70 mM KCl and 0.2 mM
EDTA, pH = 7) were loaded on a 20% polyacrylamide
gel containing Tris–Borate-EDTA (TBE) 2.5× and KCl 50
mM. The run buffer was TBE 1× containing 100 mMKCl.
For all samples, a solution of glycerol/TBE1× 100mMKCl
2:1 was added just before loading. Electrophoresis was per-
formed at 8 V/cm at a temperature close to 10◦C. Bands
were visualized by UV shadowing.
NMR spectroscopy
NMR samples were prepared at a concentration of about
3 mM, in 0.6 ml (H2O/D2O 9:1 v/v), buffer solution hav-
ing 10 mM KH2PO4/K2HPO4, 70 mM KCl and 0.2 mM
EDTA (pH 7.0). All the samples were heated for 5–10 min
at 80◦C and slowly cooled (10–12 h) to room temperature.
The solutions were equilibrated for several weeks at 4◦C.
The annealing process was assumed to be complete when
1H-NMR spectra were super-imposable on changing time.
NMR spectra were recorded with VarianUnity INOVA 500
MHz spectrometers and Varian Mercury Plus 400 MHz.
One-dimensional (1D) proton spectra of the sample in H2O
were recorded using pulsed-field gradient DPFGSE for
H2O suppression (27). 1H-chemical shifts were referenced
relative to external sodium 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS) and 19F resonances were referenced relative
to external CCl3F. Pulsed-field gradient DPFGSE sequence
was used for NOESY (28) (250 and 180 ms mixing times)
and TOCSY (29) (120 msmixing time) experiments in H2O.
All experiments were recorded using STATES-TPPI proce-
dure for quadrature detection (30). In all two-dimensional
(2D) experiments, the time domain data consisted of 2048
complex points in t2 and 400–512 fids in t1 dimension. A
relaxation delay of 1.2 s was used for all experiments.
Molecular modelling
The main conformational features of quadruplex adopted
by TBA-F4 and TBA-F13 were explored by means of a
molecular modelling study. The CFF91 force field using
CFF91 atom types set was used (31,32). The initial coor-
dinates for the starting model of TBA-F4 and TBA-F13
were taken from theNMR solution structure of the quadru-
plex d(GGTTGGTGTGGTTGG) (Protein Data Bank en-
try number 148D), with the first and best representa-
tive conformer of the twelve available ones submitted by
Feigon et al. (33) The initial d(GGTFGGTGTGGTTGG)
(TBA-F4) and d(GGTTGGTGTGGTFGG) (TBA-F13) G-
quadruplex models were built by replacing the 5-methyl
group of the thymine in the fourth and thirteenth position
with a fluorine, using the Biopolymer building tool of Dis-
cover. The calculations were performed using a distance-
dependent macroscopic dielectric constant of 4r and an in-
finite cut-off for non-bonded interactions to partially com-
pensate for the lack of solvent used (34). Using steepest de-
scent and conjugate gradient methods, the conformational
energy of the complexes was minimized until convergence
to an Root Mean Square (RMS) gradient of 0.1 kcal/mol
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A˚ was reached. Illustrations of the structure were generated
using the INSIGHT II program, version 2005 (Accelrys,
San Diego, CA, USA). All the calculations were performed
on a PC running Linux ES 2.6.9.
PT assay
PT assay on human plasma samples was measured by us-
ing Koagulab MJ Coagulation System with a specific kit
HemosIL RecombinPlasTin 2G (Instrumentation Labora-
tory, Milan, Italy). Briefly, this method relies on the high
sensitivity of thromboplastin reagent based on recombinant
human tissue factors. The addition of recombiplastin to the
plasma, in presence of calcium ions, initiates the activation
of extrinsic pathway converting the fibrinogen into fibrin,
with a formation of solid gel. The procedure was accord-
ing to the manufacturer’s instructions. In our experimental
conditions, each ODN or vehicle was incubated with 100
l of plasma at 37◦C for 3 and 15 min, after that 200 l of
the kit solution containing recombiplastin was added with
consequent activation of extrinsic pathway. For the evalua-
tion of PT at 20 M, in the apposite microtube, 2 l of the
corresponding ODN solution (1 mM in phosphate buffered
saline (PBS) buffer) or vehicle was added. The PT at final
ODN concentration of 2 Mwas determined using 2 l of
a diluted solution (0.1 mM ODN solution in PBS buffer).
The PT measurement, for each incubation time, was pro-
duced in triplicate and the average and its standard error
values were calculated and expressed as seconds. The basal
clotting timewas determined bymeasuring the clotting time
in absence of any ODN.
Nucleases stability assay
Given the molecular complexity and the large biological
variability among foetal bovine sera - making of each serum
batch a unique biological sample - nuclease biostability ex-
periments of anti-thrombin aptamers were conducted by us-
ing a range of concentrations (from 10 to 30%) of foetal
bovine serum (FBS, Gibco), diluted with Dulbecco’s Mod-
ified Eagle’s Medium (DMEM, Lonza) at 37◦C. Approxi-
mately 19 nmol of stock solution of each ODN (3 O.D.U)
were evaporated to dryness under reduced pressure and
then incubated with 200 or 250 l of FBS solutions at 37◦C.
At established times, ranging from 0 to 6 h, 50l of samples
were collected and stored at −20◦C for at least 20 min. The
samples were evaporated to dryness and then resuspended
in 10 l of gel loading buffer consisting of 30% glycerol,
30% formamide, 40% TE buffer 1× (10 mM Tris–HCl, 1
mM EDTA, pH 8.0) and 10 l of sterile water. A total of
10 l of the mixture were used for denaturing Urea PAGE,
carried out at room temperature using 20% polyacrylamide
gel in 0.5 × TBE buffer (Tris-borate-EDTA) and 7 M urea.
The degradation pattern on the gel was visualized by UV
shadowing.
RESULTS AND DISCUSSION
CD spectroscopy
The CD spectrum of the TBA is characterized by two
positive bands at 247 and 295 nm, and a negative band
Figure 2. CD spectra at 20◦C of modified TBAs and their natural counter-
part (solid line) at 100 MODN strand concentration in a buffer solution
10 mM KH2PO4/K2HPO4, 70 mM KCl (pH 7.0). (A) TBA-F4 (dotted
line) and TBA-F13 (dashed line); (B) TBA-F3 (dotted line) and TBA-F12
(dashed line); (C) TBA-F9 (dotted line) and TBA-F7 (dashed line).
at 266 nm. This profile is typical of an antiparallel G-
quadruplex in which anti and syn guanosines alternate
along the strands. Considering the distinctiveness of this
profile, a close comparison betweenCD spectra of themodi-
fied TBAs and that of their natural counterpart can be con-
sidered a useful method to straightforwardly evaluate the
effects of the F residues on the G-quadruplex structure. In
Figure 2 the CD profiles of the TBA analogues and their
natural counterpart are shown. In general, all TBA ana-
logues show CD spectra quite similar to that of the original
 at U
niversita’ di N
apoli Federico II on M
arch 31, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
10606 Nucleic Acids Research, 2015, Vol. 43, No. 22
TBA. However subtle differences suggest that CD profiles
of the TBA derivatives containing F can be conveniently
divided in three groups. In the first one, derivatives TBA-
F4 and TBA-F13 are included, showing CD profiles prac-
tically super-imposable to that of the original TBA (Figure
2A). Modified aptamers TBA-F3 and TBA-F12 belong to
the second group, that is characterized by CD profiles in
which only differences in the band intensities are evident
in comparison with the CD spectrum of TBA (Figure 2B).
Finally, derivatives TBA-F7 and TBA-F9 show CD profiles
characterized by differences in both the band intensities and
wavelengths (Figure 2C). The collectedCDdata clearly sug-
gest different effects of the F residues on the G-quadruplex
structure, according to the position in the sequence.
Thermal denaturation measurements
The differences in the behaviour of the TBA analogues are
clearlymore evident by comparing their CDmelting profiles
(Supplementary Figure S1), useful to evaluate the structural
stability in comparison with the original TBA. The ther-
modynamic parameters obtained by the van’t Hoff analy-
sis of the CD melting curves are shown in Table 1. Inspec-
tion of Table 1 reveals that none or only modest increases
of the melting temperature (Tm ∼ +3) have been observed
for TBA-F3, TBA-F12, TBA-F7 and TBA-F9 whereas, in
the cases of TBA-F4 and TBA-F13, a remarkable enhance-
ment (Tm ∼ +10) of the thermal stability has been ob-
tained. Furthermore, TBA-F9, TBA-F4 and TBA-F13 show
the higher enthalpy and entropy change upon unfolding
whereas TBA-F3, TBA-F12 and TBA-F7 have Hv.H. and
Sv.H values comparable to the unmodified TBA, within
the experimental error (Table 1). Analysis of the thermo-
dynamic parameters has revealed that the extra stability of
TBA-F4 and TBA-F13 is mainly due to the enthalpic term,
thus suggesting the formation of additional interactions in
the folded TBA-F4 and TBA-F13 in comparison with nat-
ural TBA. Interestingly, TBA-F9 shows a Hv.H value sim-
ilar to TBA-F4 and TBA-F13 but a Tm value comparable
to the unmodified TBA. The unfolding thermodynamics of
the most stable TBA analogues, namely TBA-F4 and TBA-
F13, was further investigated by usingDSC. Supplementary
Figure S2 in Supplementary Data shows the DSC melting
profiles of TBA-F4 and TBA-F13 whereas the thermody-
namic parameters are collected in Supplementary Table S1.
The Tm values are in good agreement with those obtained
by CD measurements. The comparison of the observed en-
thalpy changes with the one reported from calorimetric
study of TBA (35), confirms that the modified sequences
have a larger favourable enthalpy change being the H
∼ 50–60 kJ mol−1. In order to confirm the monomolecular
nature of TBA-F4 and TBA-F13 suggested by PAGE (vide
infra), UV melting experiments at lower concentration (4
M) were also performed (Supplementary Figure S3). As
expected for monomolecular structures, the Tm values are
independent of the concentration.
Polyacrylamide gel electrophoresis
In order to confirm that all TBA analogues preserve the
monomolecular G-quadruplex structure characteristic of
the natural TBA, the TBA modified aptamers containing
F residues were further investigated by PAGE and com-
pared to their natural counterpart. The electrophoretic
profile (Supplementary Figure S4) clearly shows that all
the TBA analogues form G-quadruplex structures with
electrophoretic motilities very similar to that of the nat-
ural TBA, thus strongly suggesting the occurring of G-
quadruplex conformations comparable to that of the origi-
nal TBA and with the same molecularity, in agreement with
the CD data.
Nuclear magnetic resonance
The ability of all the TBA analogues incorporating F to
fold into a TBA-like antiparallel G-quadruplex conforma-
tion was also assessed by NMR spectroscopy. The NMR
samples were prepared at a concentration of about 3.0 mM
in strands (0.6 ml, 90% H2O/10% D2O), having a 10 mM
potassium phosphate, 70 mMKCl and 0.2 mM EDTA (pH
7.0) buffer. The samples were heated for 5–10 min at 80◦C
and slowly cooled down (10–12 h) to room temperature. The
solutions were equilibrated at least for 1 week at 4◦C and
then their 1H-NMR spectra were recorded by using pulsed-
field gradient DPFGSE for H2O suppression (27). A com-
pleted annealing process was guaranteed by the achieve-
ment of super-imposable 1H-NMR spectra on changing
time. With the exclusion of some weak resonances, whose
relative intensities turned out to be sensitive to temperature
changes and attributable to unfolded species also present
in solution, the simple appearance of all 1H-NMR spec-
tra indicates that, in the conditions used here, the modi-
fied oligomers form mainly a single well-defined hydrogen-
bonded conformation. In fact their 1D 1H-NMR spectra
(500 MHz, T = 25◦C) (Figure 3) in the buffer conditions
utilized show the presence of eight well-defined signals in
the region 11.8–12.5 p.p.m., attributable to imino protons
involved in Hoogsteen hydrogen bonds of at least two G-
quartets and, moreover, 15 main signals in the aromatic
region, due to the presence of nine guanine H8 and five
thymine H6 singlets, and one FH6 doublet, splitted for
the spin-spin coupling between proton and fluorine. Since
the whole of data collected from CD melting experiments
and PT assays (vide infra) clearly indicate that TBA-F4 and
TBA-F13 are the most stable and active modified aptamers
of the series, we have focused our attention on these two
samples, performing further NMR investigations. A combi-
nation of the analysis of 2D NOESY (Supplementary Fig-
ures S5 and S6) and TOCSY spectra (data not shown) al-
lowed us to get the almost complete assignment (Supple-
mentary Table S2) of the non-exchangeable protons. The in-
tensities of NOESY crosspeaks between the aromatic base
proton and sugar H1’ resonances of the modified throm-
bin aptamers indicate that four Gs (G1, G5, G10 and G14)
adopt syn glycosidic conformations, while five Gs (G2, G6,
G8, G11 and G15) adopt anti conformations, where the
H8 resonances of the syn G are upfield shifted with respect
to those of the anti ones (4,36,37). All the thymidines and
the modified residue F show anti glycosidic conformations.
Then, four anti-Gs (G2, G6, G11 and G15) have classi-
cal H8/H2′-H2′′ sequential connectivities to 5′ neighbour-
ing syn-Gs (G1, G5, G10 and G14, respectively) indicat-
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Figure 3. Aromatic and imino protons regions of the 1H-NMR spectra (500 MHz, T = 25◦C) of the modified TBAs and their natural counterpart in 10
mM KH2PO4/K2HPO4, 70 mM KCl and 0.2 mM EDTA (pH 7.0).
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ing that the subunits G1-G2, G5-G6, G10-G11 and G14-
G15 are involved in the formation of a four-stranded helical
structure (underlined residues adopt a syn glycosidic con-
formation). In summary, as observed for the parent TBA,
there are 5′-GsynGanti-3′ steps along each strand of the
two quartets and moreover, the entire pattern of Nuclear
Overhauser Effects (NOEs) observed for all cited Gs indi-
cates that the backbone conformations of these tracts re-
semble those of the unmodified TBA possessing a right-
handed helix structure. The alternation of syn and anti G
residues within each strand suggests that, as for TBA, the
two modified oligomers fold into a monomolecular fold-
back G-quadruplex, characterized by two G tetrads. Two
stretches of 5′-TT-3′ and 5′-TF-3′ residues and one of 5′-
TGT-3′ could also be identified on the basis of anti–anti
connectivities. All the stretches of sequential connectivities
were arranged using the information in long-range NOE
connectivities. Similarly to the case of the parent TBA, for
both samples, there is a number of NOE connectivities ob-
served between residues not adjacent in sequence. In partic-
ular, there are NOE connectivities between H8 of G8 and
Hl′, H2′ and H2′′ of G6 and between H1′ of T9 and H8 of
G15, thus indicating that G8 and T9 residues in the TGT
loop are near to the G1-G6-G10-G15 tetrad both in the
TBA-F4 that in the TBA-F13. NOEs are also present be-
tween H8 of G2 and H2′ and H2′′ of F4 and between H8 of
G11 andmethyl, H2′ andH2′′ of T13 in the case ofTBA-F4.
Correspondingly, as far as TBA-F13 is concerned, there are
NOE connectivities between H8 of G2 and methyl, H2′ and
H2′′ of T4 and betweenH8 ofG11 andH2′ andH2′′ of F13.
Complementary information is provided by the NOEs from
the methyl of T13 with H1′, H2′ and H2′′ of G2, in the case
of TBA-F4, and from the methyl of T4 with H1′ H2′ and
H2′′ of G11, in the case of TBA-F13. For both the samples,
this collection of NOEs places the residues in position 4 and
13 close to the G2-G5-G11-G14 tetrad. The whole of NMR
data showed that, as strongly suggested by the CD experi-
ments, these two modified aptamers adopt G-quadruplex
structures strictly resembling the parent one.
The presence of a fluorine atom in each sequence has
given us the opportunity to further investigate the modified
TBAs by 19F-NMR spectroscopy. Since it is generally ac-
cepted that TBA binds and inhibits thrombin through the
TT loops, only G-quadruplex structures formed by TBA-
F3,TBA-F4, TBA-F12 and TBA-F13 have been analysed by
this technique. Proton-decoupled fluorine 1DNMRspectra
(400 MHz, T = 25◦C) of all the samples exhibit the occur-
rence of one uppermost signal in the region −62.0 to −59.0
p.p.m. (Supplementary Figure S7), attributable to the fluo-
rine nucleus of the modified residue F, thus confirming the
presence in solution of a main conformation. Furthermore,
taking into account that the 19F chemical shifts are particu-
larly sensitive to the chemical environment (38,39), the very
similar values for TBA-F3 and TBA-F12, on one hand, and
TBA-F4 andTBA-F13, on the other hand, has allowed us to
confirm the almost identical conformation and behaviour
of the residues in each couple.
Molecular modelling
Molecular models for both TBA-F4 and TBA-F13 have
been built. As expected, the replacement of a methyl group
with a fluorine atom doesn’t significantly affect the general
folding of the modified G-quadruplex structures, compared
to the original TBA, as already suggested by NMR data.
However, the close inspection of the TT loop regions in the
TBA-F13 model reveals a good stacking between F13 and
G11 involved in the formation of the adjacent G-tetrad, in
which the fluorine atomwith a partially negative charge is in
close proximity to C4 of the guanosine with a partially pos-
itive charge (Figure 4, left). Similarly, in the TBA-F4model,
the fluorine atom of F4 is in close proximity to the C4 of the
G2 (Figure 4, right). Althoughmore accurate investigations
concerning the origin of the thermodynamic parameter dif-
ferences observed for these modified aptamers are beyond
the aim of this paper, the increase in the enthalpy change
observed for TBA-F4 and TBA-F13 could be tentatively ex-
plained by the more effective dipole–dipole interactions be-
tween fluorine and carbon atoms of the adjacent G-tetrad,
compared to the parent TBA.
PT assay
In order to evaluate the anticoagulant activity of the TBA
analogues containing a F residue, the modified sequences
have been subjected to PT assay. This analysis has shown
that all TBA derivatives preserve their anticoagulant activ-
ity, although in different extents, depending on the position
of the F residues in the sequence (Figure 5). TBA-F4 and
TBA-F13 have shown a significant enhancement of the anti-
coagulant activity compared to the original TBA. In partic-
ular these compounds prolonged the PT values more than
TBA when they are incubated for 15 min at the concentra-
tion of 2 M (Figure 5B) and for 3 and 15 min at 20 M
(Figure 5C and 5D). Conversely, the anticoagulant activ-
ity of TBA-F3 has turned out lower than the natural TBA.
As far as TBA-F7, TBA-F9 and TBA-F12 are concerned,
no noteworthy differences with the original TBA have been
observed. These results indicate that TBA-F4 possesses the
best anticoagulant activity among all the TBA analogues
tested and it is more efficient than natural TBA at both
concentrations tested. The data obtained have clearly high-
lighted that it is possible to significantly improve the antico-
agulant activity of TBA in vitro also through tiny chemical
modifications.
Nucleases stability assay
In order to test the resistance in biological environments,
the most active modified aptamers, namely TBA-F4 and
TBA-F13, were undergone to a degradation assay in foetal
bovine serum (Supplementary Figure S8) and analysed by
gel electrophoresis. As expected considering the very small
chemical modification compared to the parent TBA, results
clearly show that TBA analogues behave as their natural
counterpart and, then, the replacement of a methyl group
by a fluorine atom is not enough to increase the resistance
in biological environments. On the other hand, several in-
vestigations have been reported indicating that a suitable re-
sistance to nucleases of modified TBA can be obtained by
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Figure 4. Bottom view representations of the molecular models of the quadruplexes formed by TBA-F13 (left) and TBA-F4 (right). The structures are
oriented with the 5′ and 3′-ends upward. The TGT loop and the G1-G6-G10-G15 tetrad have been omitted for clarity. Backbones and bases are depicted in
coloured ‘stick’ (carbons, green; nitrogens, blue; oxygens, red; hydrogens, white; fluorine, yellow). The F13 (left) and F4 (right) residues and the respectively
overlying G11 and G2 are reported in ball and sticks, in order to point out the effectiveness of the stacking interaction between them.
Figure 5. PT values of the modified TBAs and their natural counterpart at different ODN concentrations and incubation times (A and C: 3 min.; B and
D: 15 min.). See experimental section for details. ***P < 0.001 versus vehicle, ◦P < 0.05, ◦◦P < 0.01, ◦◦◦P < 0.001 versus TBA (n = 3).
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simple specific modifications of the sugar-phosphate back-
bone without affecting the loops involved in the interaction
with the target protein (for example see 18,19,40).
CONCLUSIONS
The sequence of TBA is the final product of a selection pro-
cess and of the subsequent truncation studies (3). Therefore,
the peculiar ‘chair-like’ G-quadruplex structure adopted by
this sequence has been selected to bind with high affinity
and selectivity the thrombin. In view of a possible thera-
peutic use of this aptamer several modifications have been
proposed in order to improve both its physical-chemical
and biological properties (41). However, each loop modi-
fication, by altering the conformation of the aptamer which
has been optimized by the SELEX process to bind throm-
bin, can revert the favourable properties, particularly if this
modification concerns residues T4, T9 and T13 (10,12,16).
As a matter of fact, improvements of the TBA properties
have been obtained only by modifying the sugar-phosphate
backbone concerning residues T7, T3 and T12 (9-14). In an
attempt to introducemodifications and, at the same time, to
preserve the conformation of the negatively charged sugar-
phosphate backbone of the TT loop interacting with the
positive exosite I of the thrombin (8), we have focused our
attention on the aromatic bases of the loop residues. In a
previous paper (20), we improved thermal stability and/or
anticoagulant activity by substituting individual thymines
(position T3, T7 and T9) with 5-hydroxymethyluracil bases.
In this paper we show that the replacement of thymine T4
or T13 with 5-fluorouracil results in a significant improve-
ment of both stability and biological activity, particularly
considering the minor change performed on TBA (a flu-
orine atom replacing a methyl group). It should be noted
that examples of enhancements of TBA properties by site-
specific substitutions in positions T4 and T13 are unprece-
dented in literature. Taking into consideration the availabil-
ity of modified thymidine phosphoramidites from commer-
cial sources and the possibility to prepare further modified
thymidines from synthetic approaches described in the lit-
erature, our results open up new perspectives of improving
TBA properties through tiny and straightforward chemi-
cal modifications, which would be worth testing also for
other aptamers. Recently several ‘second generation’ antico-
agulant aptamers have been described in literature. Among
these, the duplex-quadruplex modular aptamer (42,43,44)
dimeric DNA aptamers (45) and the bivalent aptamer (46)
are particularly noteworthy. It should be noted that the bio-
logical activity of all these aptamers could benefit from the
site specific replacement here described, since they preserve
the peculiar sequence of TBA (Table 1) folding in the an-
tiparallel G-quadruplex, as the structural component inter-
actingwith the thrombin. Furthermore, it would be interest-
ing to explore the properties of TBA analogues in which two
ormore different types ofmodified residues have been intro-
duced in specific positions, with the aim to test the possibil-
ity of additive or synergic effects between the modifications.
At the moment, investigations concerning TBA analogues
containing both 5-hydroxymethyl-2′-deoxyuridine and 5-
fluoro-2′-deoxyuridine have been planned in our laboratory.
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